| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.093 | 0.09 |